Design, Synthesis and Biological Evaluation of Novel Osimertinib-Based HDAC and EGFR Dual Inhibitors

Herein a novel series of histone deacetylases (HDACs) and epidermal growth factor receptor (EGFR) dual inhibitors were designed and synthesized based on the structure of the approved EGFR inhibitor osimertinib (AZD9291). Among them, four compounds 5D, 5E, 9D and 9E exhibited more potent total HDAC i...

Descripción completa

Detalles Bibliográficos
Autores principales: Dong, Hang, Yin, Hao, Zhao, Chunlong, Cao, Jiangying, Xu, Wenfang, Zhang, Yingjie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6651501/
https://www.ncbi.nlm.nih.gov/pubmed/31261881
http://dx.doi.org/10.3390/molecules24132407

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6651501/
https://www.ncbi.nlm.nih.gov/pubmed/31261881
http://dx.doi.org/10.3390/molecules24132407

Ejemplares similares